| Literature DB >> 15283897 |
Gerald L Andriole1, Douglas Reding, Richard B Hayes, Philip C Prorok, John K Gohagan.
Abstract
The Prostate, Lung, Cancer, and Ovarian Cancer Screening Trial is a randomized, multicenter, study evaluating whether screening for prostate, lung, colon, and ovarian cancer will reduce cancer-specific mortality. More than 155,000 participants have been identified and will be monitored through 2015. A biorepository of screened individuals and control participants has been created. Together, the data derived from the intervention and control arms and material in the biorepository provide a valuable resource to allow identification and testing of novel biomarkers for human disease. Copyright 2004 Elsevier Inc.Entities:
Mesh：
Substances：
Year: 2004 PMID： 15283897 DOI： 10.1016/j.urolonc.2004.04.013
Source DB: PubMed Journal: Urol Oncol ISSN： 1078-1439 Impact factor: 3.498